Market Access News | pharmaphorum

News

UK starts 'world-first' gonorrhoea vaccination push

The UK has started a gonorrhoea vaccination programme designed to prevent thousands of infections and save the NHS millions of pounds.

News

Sanofi grabs Chinese rights to Arrowhead rare disease drug

Sanofi has paid $130 million upfront for Chinese rights to an Arrowhead Pharma drug for rare disease familial chylomicronaemia syndrome.

News

NHS broadens access to haemophilia A drug Hemlibra

More people living with haemophilia A will be able to get access to Roche/Chugai's Hemlibra thanks to a commissioning agreement with NHS England.

News

Trump gives pharma ultimatum on most favoured nation pricing

President Trump has given 17 pharma companies until 29th September to commit to providing lower prices "to every single Medicaid patient."

News

Tidmarsh to stand in for Prasad's role at CBER

Following Vinay Prasad's abrupt departure as CBER director, FDA has asked CDER head George Tidmarsh to take on both roles while a successor is sought.

News

NICE CEO to step down by year-end

Sam Roberts is stepping down from the role of NICE CEO to support her children through a difficult time, and a search for her replacement is underway.

UK starts 'world-first' gonorrhoea vaccination push

Sanofi grabs Chinese rights to Arrowhead rare disease drug

NHS broadens access to haemophilia A drug Hemlibra

Trump gives pharma ultimatum on most favoured nation pricing

Tidmarsh to stand in for Prasad's role at CBER

NICE CEO to step down by year-end

UK's Mission divests kidney drug to Dimerix for $292m

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks